Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/19158
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVital, SA-
dc.contributor.authorBecker, F-
dc.contributor.authorHolloway, PM-
dc.contributor.authorRussell, J-
dc.contributor.authorPerretti, M-
dc.contributor.authorGranger, DN-
dc.contributor.authorGavins, FNE-
dc.date.accessioned2019-09-23T11:58:39Z-
dc.date.available2016-05-31-
dc.date.available2019-09-23T11:58:39Z-
dc.date.issued2016-05-31-
dc.identifier.citationVital SA, Becker F, Holloway PM, Russell J, Perretti M, Granger DN, Gavins FN. Formyl-peptide receptor 2/3/lipoxin A4 receptor regulates neutrophil-platelet aggregation and attenuates cerebral inflammation: impact for therapy in cardiovascular disease. Circulation. 2016 May 31;133(22):2169-79.en_US
dc.identifier.issn0009-7322-
dc.identifier.issnhttp://dx.doi.org/10.1161/circulationaha.115.020633-
dc.identifier.issn1524-4539-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/19158-
dc.format.extent2169 - 2179-
dc.languageen-
dc.language.isoenen_US
dc.publisherOvid Technologies (Wolters Kluwer Health)en_US
dc.subjectFormyl peptide receptoren_US
dc.subjectInflammationen_US
dc.subjectIschemia reperfusion injuryen_US
dc.subjectStrokeen_US
dc.subjectIschemicen_US
dc.titleFormyl-Peptide Receptor 2/3/Lipoxin A 4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammationen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1161/circulationaha.115.020633-
dc.relation.isPartOfCirculation-
pubs.issue22-
pubs.publication-statusPublished-
pubs.volume133-
dc.identifier.eissn1524-4539-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf1.39 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.